COMPARATIVE STUDIES ON ACTIVITIES OF ANTIMICROBIAL AGENTS AGAINST CAUSATIVE ORGANISMS ISOLATED FROM PATIENTS WITH URINARY TRACT INFECTIONS (2002)
-
- KUMAMOTO YOSHIAIU
- Department of Urology, Sapporo Medical University School of Medicine
-
- TSUKAMOTO TAIJI
- Department of Urology, Sapporo Medical University School of Medicine
-
- MATSUKAWA MASANORI
- Department of Urology, Sapporo Medical University School of Medicine
-
- KUNISHIMA YASUHARU
- Department of Urology, Sapporo Medical University School of Medicine
-
- HIROSE TAKAOKI
- Department of Urology, Hokkaido Syakai Hoken Hospital
-
- YAMAGUTI OSAMU
- Department of Urology, Fukushima Medical University
-
- ISHIBASHI KEI
- Department of Urology, Fukushima Medical University
-
- SHIGETA SHIRO
- Department of Microbiology, Fukushima Medical University
-
- SUZUTANI TATSUO
- Department of Microbiology, Fukushima Medical University
-
- YOSHIDA HIROSHI
- Department of Clinical Laboratory Medicine, Fukushima Medical University
-
- IMAFUKU YUUJI
- Department of Clinical Laboratory Medicine, Fukushima Medical University
-
- MURAI MASARU
- Department of Urology, Keio University School of Medicine
-
- WATANABE KIYOAKI
- Department of Microbiology, Toho University School of Medicine
-
- KOBAYASHI YOSHIO
- Department of Microbiology, Toho University School of Medicine
-
- UCHIDA HIROSHI
- Department of Microbiology, Toho University School of Medicine
-
- MATSUDA SEIJI
- Department of Urology, Gifu University School of Medicine
-
- SATO SHINICHI
- Department of Urology, Kyoto Second Red Cross Hospital
-
- FUJIME MAKOTO
- Department of Clinical Laboratory, Kyoto Second Red Cross Hospital
-
- FUJITA KAZUHIKO
- Department of Clinical Laboratory, Kyoto Second Red Cross Hospital
-
- NAITO SEIJI
- Department of Urology Osaka National Hospital
-
- EGASHIRA TOSHIHISA
- Department of Urology Osaka National Hospital
-
- KOHNO SHIGERU
- Department of Clinical Laboratories, Osaka National Hospital
-
- MIYAZAKI YOSHITSUGU
- Department of Clinical Laboratories, Osaka National Hospital
-
- IGARI JUN
- Central Clinical Laboratories, Keio University School of Medicine
-
- OGURI TOYOKO
- Department of Gynecology, Koto Hospital
-
- YAMAGUCHI KEIZO
- Department of Clinical Laboratories, Koto Hospital
-
- FURUYA NOBUHIKO
- Department of Clinical Laboratories, Koto Hospital
-
- DEGUCHI TAKASHI
- Department of Urology, Juntendo University School of Medicine
-
- ISHIHARA SATOSHI
- Department of Urology, Juntendo University School of Medicine
-
- OOE HIROSHI
- Department of Clinical Pathology, Juntendo University School of Medicine
-
- NISHIKAWA MINEKO
- Department of Clinical Laboratories, Juntendo University Hospital
-
- OKA TOSHITSUGU
- Division of Urology, Kobe University Graduate School of Medicine
-
- KITAMURA MASAYA
- Division of Urology, Kobe University Graduate School of Medicine
-
- FUKUHARA YOSHINORI
- Department of Urology, Okayama University Graduate School of Medicine and Dentistry
-
- KAMIDONO SADAO
- Department of Urology, School of Medicine, University of Occupational and Environmental Health
-
- ARAKAWA SOICHI
- Department of Urology, School of Medicine, University of Occupational and Environmental Health
-
- KUMON HIROMI
- Department of Urology, Kyushu University Graduate School of Medicine
-
- MONDEN KOICHI
- Department of Urology, Kyushu University Graduate School of Medicine
-
- MATSUMOTO TETSURO
- Second Department of Internal Medicine, Nagasaki University Graduate School of Medicine
-
- TAKAHASHI KOICHI
- Second Department of Internal Medicine, Nagasaki University Graduate School of Medicine
-
- HIRAKATA YOICHI
- Department of Laboratory Medicine, Nagasaki University Graduate School of Medicine
-
- AOKI SIHO
- Department of Laboratory Medicine, Nagasaki University Graduate School of Medicine
Bibliographic Information
- Other Title
-
- 尿路感染症分離菌に対する経口ならびに注射用抗菌薬の抗菌力比較 (第24報2002年)
- I. SUSCEPTIBILITY DISTRIBUTION
- その1.感受性について
Abstract
The bacterial strains isolated from 491 patients diagnosed as having urinary tractinfections (UTIs) in 13 institutions in Japan were supplied between August 2002 and July 2003. The susceptibilities of them to many kinds of antimicrobial agents were investigated. Of them, 578 strains were estimated as causative bacteria and used for the investigation. The number of them was 578 strains consisting of 177 Gram-positive bacterial strains (30.6%) and 401 Gram-negative bacterial strains (69.4 %).<BR>Against Staphylococcus aureus, vancomycin (VCM) showed a strong activity and prevented the growth of all strains with 1μg/mL. The susceptibility of Staphylococcus epidermidis to cephems including cefotiam (CTM) was relatively good. Against Enterococcus faecalis, ampicillin (ABPC), imipenem (IPM), and VCM showed the strongest antibacterial activity (MIC90: 2-4μg/mL). In addition, the low sensitive strains (MIC: ≥256μg/mL) to clarithromycin (CAM) were detected at 48.3% but none to cefozopran (CZOP). The antibacterial activity of cephems to Escherichia coli was generally good, and especially CZOP and cefpirome (CPR) showed the highest activity (MIC90: ≤0.125μg/mL). Quinolone resistant E. coli was detected at frequency of 13.5%, which was higher than that in the last year. The antibacterial activity of cephems to Citrobacter freundii was generally lowbut CZOP and CPR had a strong acitivity (MIC90: 0.25 and 0.5 μg/mL, respectively). The antibacterial activity of cephems to Klebsiella pneumoniae was good and especially cefmenoxime (CMX), cefixime (CFIX), flomoxef (FMOX), CPR, and CZOP showed stronger activity (MIC90: ≤0.125μg/mL). Against Serratia marcescens, meropenem (MEPM) had the highest antibacterial activity followed by CPR and CZOP. Against Proteus mirabilis, CMX, ceftazidime (CAZ), CPR, MEPM, carumonam (CRMN), and levofloxacin (LVFX) showed the strongest activity (MIC90: ≤0.125μg/mL). Among other cephems, CZOP and CFIX were also strong (MIC90: 0.25μg/mL). The antibacterial activity of the drugs to Pseudomonas aeruginosa wasgenerally low, and MIC90 of all the drugs were ranged from 64 to≥256μg/mL except IPM and amikacin (AMK) having 16μg/mL. The antibacterial activity of CZOP was relatively good (MIC50: 8μg/mL).
Journal
-
- The Japanese Journal of Antibiotics
-
The Japanese Journal of Antibiotics 57 (3), 246-274, 2004
Japan Antibiotics Research Association
- Tweet
Details 詳細情報について
-
- CRID
- 1390282680470073344
-
- NII Article ID
- 130004131046
-
- COI
- 1:STN:280:DC%2BD2cvms1eqtw%3D%3D
-
- ISSN
- 21865477
- 03682781
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed